Skip to main content
. 2020 Sep 3;169:112572. doi: 10.1016/j.bios.2020.112572

Fig. 1.

Fig. 1

Graphical illustrations of the COVID-19 related immunoassays that were performed with our microfluidic chemiluminescent ELISA platform, including (A) affinity evaluation of calibration antibodies, (B) detection of circulating anti-SARS-CoV-2 S1 IgG in serum samples, and (C) detection of SARS-CoV-2 antigens such as S1 and N protein.